awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q54239807-C161AFD9-1DC7-4E83-9D6F-DC8ECBBED5E8
Q54239807-C161AFD9-1DC7-4E83-9D6F-DC8ECBBED5E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54239807-C161AFD9-1DC7-4E83-9D6F-DC8ECBBED5E8
Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection.
P2860
Q54239807-C161AFD9-1DC7-4E83-9D6F-DC8ECBBED5E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54239807-C161AFD9-1DC7-4E83-9D6F-DC8ECBBED5E8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c4b3103f7a412fb81aee1a242a77f0912be6f039
P2860
Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice.